Literature DB >> 31949802

p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion.

Xiaobo Zhang1, Danhua Shen1.   

Abstract

OBJECTIVE: To describe the natural history of low-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade I (LSIL/CIN1), and to analyze the predictive values of p16INK4a and Ki-67 for LSIL/CIN1 progression.
METHODS: From January 2013 to January 2016, 264 patients were diagnosed with CIN1 by colposcopy-assisted biopsy and were followed up at 1-year intervals at Peking University People's Hospital. We measured expression levels of biomarkers p16INK4a and Ki67 to predict progression, persistence, or regression of the disease. We used chi-square tests and logistic regression analysis to explore the relationships among LSIL/CIN1 progression, p16INK4a/Ki-67 expression, and patient age.
RESULTS: Among 264 patients with LSIL/CIN1, p16INK4a, Ki-67 expression and patient age > 30 years old were significantly associated with progression. Univariate analysis showed that age was not a risk factor for progression (P > 0.05) but that p16INK4a and Ki-67 expression were significantly associated with the progression (P < 0.05). Multivariate analysis showed that p16INK4a-positivity and high expression of Ki-67 protein were associated with LSIL/CIN1 progression, with odds ratios (OR) and 95% confidence intervals (CI) of 10.95 (3.04-39.53), and 9.7 (2.77-34.03), respectively.
CONCLUSION: p16INK4a-positivity and high expression of Ki-67correlated with LSIL/CIN1 progression. These markers may be independent predictors of LSIL/CIN1 progression. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Ki-67; LSIL/CIN1; follow-up; p16INK4a; pathological outcome

Year:  2018        PMID: 31949802

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  3 in total

1.  Analysis of factors affecting the prognosis of patients with cervical intraepithelial neoplasia 2.

Authors:  Xiaobo Zhang; Yougui Xu; Tianyu Meng; Danhua Shen
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

2.  Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.

Authors:  Zavuga Zuberi; Alex Mremi; Jaffu O Chilongola; George Semango; Elingarami Sauli
Journal:  PLoS One       Date:  2021-10-27       Impact factor: 3.240

3.  Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial.

Authors:  Attila Louis Major; Vladimír Dvořák; Jana Schwarzová; Aleš Skřivánek; Tomáš Malík; Marek Pluta; Ivanna Mayboroda; Etienne Marc Grandjean
Journal:  Arch Gynecol Obstet       Date:  2020-11-20       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.